牛黄清心丸治疗老年高血压眩晕伴焦虑抑郁患者及对其血清炎症因子和神经递质的影响
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R259;R277.7

基金项目:

中国民族医药学会科研项目(2022Z1001-640201);


Effect of Niuhuang Qingxin Pill on serum inflammatory factors and neurotransmitters in elderly patients with hypertension and vertigo accompanied by anxiety and depression
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的:探讨牛黄清心丸治疗老年高血压眩晕伴焦虑抑郁患者及对其血清炎症因子和神经递质的影响。方法:将122例老年高血压眩晕伴焦虑抑郁患者分为观察组(n=61)、对照组(n=61)。对照组予以西医常规治疗;观察组在此基础上予以牛黄清心丸治疗,两组均治疗7 d。观察两组患者治疗前后中医证候积分、焦虑自评量表(SAS)评分、抑郁自评量表(SDS)评分及心电功能[全部窦性RR间期的标准差(SDNN)、全程相邻RR间期差值的均方根(rMSSD)、全部相邻的RR间期差值>50 ms的百分数(pNN50)、极低频功率(VLF)]、血压、炎症因子[白细胞介素-1β(IL-1β)、IL-6、肿瘤坏死因子α(TNF-α)]、神经递质[5-羟色胺(5-HT)、去甲肾上腺素(NE)、多巴胺(DA)]水平变化情况,并比较两组临床疗效及不良反应。结果:治疗7 d后,观察组的总有效率为91.80%,对照组为75.41%,观察组高于对照组(P<0.05)。与治疗前比较,治疗后两组的SAS评分、中医证候积分、SDS评分均下降(P<0.001),且观察组低于对照组(P<0.001)。与治疗前比较,两组治疗后的SDNN、rMSSD、pNN50、VLF均升高,收缩压、舒张压均下降,且观察组的各项指标改善幅度均优于对照组(P<0.05)。治疗后,两组的IL-1β、IL-6、TNF-α均较治疗前下降(P<0.05),且观察组低于对照组(P<0.001)。治疗后,两组的5-HT、NE、DA均较治疗前升高(P<0.05),且观察组高于对照组(P<0.001)。观察组的不良反应发生率(1.64%)与对照组的(4.92%)比较,差异无统计学意义(P>0.05)。随访3个月,两组均未见迟发性不良反应,观察组再发高血压眩晕、焦虑进展、抑郁进展发生率低于对照组(P<0.05)。结论:牛黄清心丸治疗老年高血压眩晕伴焦虑抑郁患者可有效抑制炎症因子水平,上调神经递质水平,控制血压,改善神经功能,缓解眩晕、焦虑、抑郁等临床症状,疗效显著且能维持中长期疗效,安全可靠。

    Abstract:

    Objective: To explore the effects of Niuhuang Qingxin Pill on serum inflammatory factors and neurotransmitters in elderly patients with hypertension-induced vertigo accompanied by anxiety and depression.Methods: 122 elderly patients with hypertensive vertigo with anxiety and depression were divided into an observation group (n=61) and a control group (n=61). The control group was given conventional Western medicine treatment, while the observation group was given Niuhuang Qingxin Pill on top of that. All were treated for 7 days. The changes in TCM syndrome scores, Self-Rating Anxiety Scale (SAS) scores, Self-Rating Depression Scale (SDS) scores, ECG function [Standard deviation of all NN intervals (SDNN), root mean square of successive RR interval differences (rMSSD), percentage of all successive RR interval differences greater than 50ms (pNN50), very low frequency power (VLF)], blood pressure, inflammatory factors [interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α)], and neurotransmitters [5-hydroxytryptamine (5-HT), norepinephrine (NE), dopamine (DA)] levels were observed in both groups before and after treatment. The clinical efficacy and adverse reactions of the two groups of patients were compared.Results: After 7 days of treatment, the total effective rate of the observation group was 91.80%, while that of the control group was 75.41%; the clinical efficacy of the observation group was higher than that of the control group (P0.05). After 3 months of follow-up, there were no delayed adverse reactions in the two groups; the incidence of recurrent hypertension vertigo, anxiety progression, and depression progression in the observation group was lower than that in the control group (P<0.05).Conclusion: Niuhuang Qingxin Pills can effectively inhibit the level of inflammatory factors, up-regulate the level of neurotransmitters, control blood pressure, improve neurological function, relieve vertigo, anxiety, depression, and other clinical symptoms in the treatment of elderly patients with hypertensive vertigo with anxiety and depression. The curative effect is remarkable, it can maintain the medium and long-term curative effect, and the safety is reliable.

    参考文献
    相似文献
    引证文献
引用本文

王戈;唐启盛.牛黄清心丸治疗老年高血压眩晕伴焦虑抑郁患者及对其血清炎症因子和神经递质的影响[J].川北医学院学报,2026,41(2):154-159.

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-03-05
  • 出版日期: 2026-02-28
文章二维码